Expression of oligodendrocyte and myelin genes is not altered in peripheral blood cells of patients with first-episode schizophrenia and bipolar disorder

Bipolar Disorders

Volumn 12, Issue 1, 2010, Pages 107-109

  Gutiérrez Fernández, Arantza ^a   González Pinto, Ana ^b   Vega, Patricia ^b   Barbeito, Sara ^b   Matute, Carlos ^a  

^a UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE SALUD MENTAL CIBERSAM   (Spain)

Author keywords

Bipolar disorder; First psychotic episode; Myelin; Oligodendrocyte; Schizophrenia

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; ATYPICAL ANTIPSYCHOTIC AGENT; LITHIUM SALT; MESSENGER RNA; MOOD STABILIZER; MYELIN; MYELIN BASIC PROTEIN;

ADULT; BIPOLAR DISORDER; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; LETTER; MAJOR CLINICAL STUDY; OLIGODENDROGLIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCHIZOPHRENIA;

2',3'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; ADULT; BIPOLAR DISORDER; BLOOD CELLS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MALE; MYELIN BASIC PROTEINS; MYELIN SHEATH; OLIGODENDROGLIA; RNA, MESSENGER; SCHIZOPHRENIA;

EID: 75249084374     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2009.00776.x     Document Type: Letter

References (11)

1. Hakak Y, Walker JR, Li C. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci 2001, 98:4746-4751.
2. Tkachev D, Mimmack ML, Ryan MM. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 2003, 362:798-805.
3. Gladkevich A, Kauffman HF, Korf J. Lymphocytes as a neural probe: potential for studying psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry 2004, 28:559-576.
4. Liew CC, Ma J, Tang HC, Zheng R, Dempsey AA. The peripheral blood transcriptome dynamically reflects system wide biology: a potential diagnostic tool. J Lab Clin Med 2006, 147:126-132.
5. Niculescu HL, Kurian SM, Yehyawi N. Identifying blood biomarkers for mood disorders using convergent functional genomics. Mol Psychiatry 2009, 14:156-174.
6. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13:261-276.
7. Vallejo-Illarramendi A, Domercq M, Perez-Cerda F, Ravid R, Matute C. Increased expression and function of glutamate transporters in multiple sclerosis. Neurobiol Dis 2006, 21:154-164.
8. Vawter MP, Ferran E, Galke B, Cooper K, Bunney WE, Byerley W. Microarray screening of lymphocyte gene expression differences in a mutiplex schizophrenia pedigree. Schizophr Res 2004, 67:41-52.
9. Bowden NA, Weidenhofer J, Scott RJ. Preliminary investigation of gene expression profiles in peripheral blood lymphocytes in schizophrenia. Schizophr Res 2006, 82:175-183.
10. Bruno S, Cercignani M, Ron MA. White matter abnormalities in bipolar disorder: a voxel-based diffusion tensor imaging study. Bipolar Disord 2008, 10:460-468.
11. Adler CM, DelBello MP, Jarvis K, Levine A, Adams J, Strakowski SM. Voxel-based study of structural changes in first-episode patients with bipolar disorder. Biol Psychiatry 2007, 61:776-781.